Infinity Pharmaceuticals Alpha and Beta Analysis
| INFIDelisted Stock | USD 0.04 0.03 42.86% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Infinity Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Infinity Pharmaceuticals over a specified time horizon. Remember, high Infinity Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Infinity Pharmaceuticals' market risk premium analysis include:
Beta 0.56 | Alpha (1.34) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Infinity |
Infinity Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Infinity Pharmaceuticals market risk premium is the additional return an investor will receive from holding Infinity Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Infinity Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Infinity Pharmaceuticals' performance over market.| α | -1.34 | β | 0.56 |
Infinity Pharmaceuticals Fundamentals Vs Peers
Comparing Infinity Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Infinity Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Infinity Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Infinity Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Infinity Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Infinity Pharmaceuticals to competition |
| Fundamentals | Infinity Pharmaceuticals | Peer Average |
| Return On Equity | -35.21 | -0.31 |
| Return On Asset | -0.61 | -0.14 |
| Operating Margin | (15.70) % | (5.51) % |
| Current Valuation | (9.46 M) | 16.62 B |
| Shares Outstanding | 90.76 M | 571.82 M |
| Shares Owned By Insiders | 2.36 % | 10.09 % |
| Shares Owned By Institutions | 23.48 % | 39.21 % |
Infinity Pharmaceuticals Opportunities
Infinity Pharmaceuticals Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Israel Existing Upcoming Data Center Database Investment Details, Load Capacity, Infrastructure Overview, Project Status and More. | 07/21/2023 |
2 | Cherokee Uniforms Donates Scrubs Uniforms to United Vessels of Love Foundation | 08/02/2023 |
3 | Bragar Eagel Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital and Infinity and Encourages Investors to Contact ... | 08/22/2023 |
4 | Infinity Pharmaceuticals, Inc. Class Action Alert Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Infinity Pharmaceuticals, Inc. Securities ... | 08/24/2023 |
5 | ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action INFI | 08/25/2023 |
6 | INFI Stock News Investors with Significant Losses in Infinity Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery | 08/28/2023 |
7 | Infinity Pharmaceuticals Receives New Coverage from Analysts at StockNews.com | 08/29/2023 |
8 | ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of 100K to Secure Counsel Before Important Deadline ... | 08/30/2023 |
9 | SHAREHOLDER ACTION ALERT The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of 100,000 to Contact the Firm | 09/01/2023 |
10 | Three execs leave Infinity Pharmaceuticals after failed merger, layoffs | 09/05/2023 |
11 | INFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc. | 09/06/2023 |
12 | DEADLINE ALERT for KEY, LYV, APLD, and INFI The Law Offices ... - The Bakersfield Californian | 09/07/2023 |
About Infinity Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Infinity or other delisted stocks. Alpha measures the amount that position in Infinity Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Infinity Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Infinity Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Infinity Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Infinity Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Infinity Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Infinity Pharmaceuticals' management manipulating its earnings.
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View |
Build Portfolio with Infinity Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Infinity Pharmaceuticals information on this page should be used as a complementary analysis to other Infinity Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Infinity Stock
If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |